<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: To examine the association of serum cystatin C with the incidence of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> over a 15 year follow-up period </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The 15 year cumulative incidence of <z:mp ids='MP_0002055'>diabetes</z:mp> was measured in a cohort of Beaver Dam Eye Study participants (n = 3,472, 1988-2003) </plain></SENT>
<SENT sid="2" pm="."><plain>A person was defined as developing <z:mp ids='MP_0002055'>diabetes</z:mp> (a positive history of <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> treated with insulin, oral hypoglycaemic agents and/or diet, or elevations in glycosylated <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> levels) in the absence of <z:mp ids='MP_0002055'>diabetes</z:mp> at baseline </plain></SENT>
<SENT sid="3" pm="."><plain>The relation of cystatin C and other risk factors to incident type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was determined using discrete time extension of the proportional hazards model </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The 15 year cumulative incidence of <z:mp ids='MP_0002055'>diabetes</z:mp> was estimated to be 9.6% </plain></SENT>
<SENT sid="5" pm="."><plain>After controlling for age, sex, body mass index, smoking status, glycosylated <z:chebi fb="34" ids="35143">haemoglobin</z:chebi>, <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> status and <z:hpo ids='HP_0000822'>hypertension</z:hpo> status, serum cystatin C at baseline was associated with the 15 year cumulative incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (OR per log of cystatin C unit 2.19, 95% CI 1.02-4.68) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS/INTERPRETATION: These findings show a positive relationship of serum cystatin C levels with the incidence of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> independently of confounding risk factors </plain></SENT>
<SENT sid="7" pm="."><plain>The findings strongly suggest the need for further evaluation of the potential importance of cystatin C in the pathogenesis of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
</text></document>